Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
H5N1 clade 2.3.4.4b dynamics in experimentally infected calves and cows.
Halwe NJ, Cool K, Breithaupt A, Schön J, Trujillo JD, Nooruzzaman M, Kwon T, Ahrens AK, Britzke T, McDowell CD, Piesche R, Singh G, Pinho Dos Reis V, Kafle S, Pohlmann A, Gaudreault NN, Corleis B, Ferreyra FM, Carossino M, Balasuriya UBR, Hensley L, Morozov I, Covaleda LM, Diel DG, Ulrich L, Hoffmann D, Beer M, Richt JA. Halwe NJ, et al. Among authors: hensley l. Nature. 2024 Sep 25. doi: 10.1038/s41586-024-08063-y. Online ahead of print. Nature. 2024. PMID: 39321846
Experimental inoculation of pigs with monkeypox virus results in productive infection and transmission to sentinels.
Mantlo E, Trujillo JD, Gaudreault NN, Morozov I, Lewis CE, Matias-Ferreyra F, McDowell C, Bold D, Kwon T, Cool K, Balaraman V, Madden D, Artiaga B, Souza-Neto J, Doty JB, Carossino M, Balasuriya U, Wilson WC, Osterrieder N, Hensley L, Richt JA. Mantlo E, et al. Among authors: hensley l. Emerg Microbes Infect. 2024 Dec;13(1):2352434. doi: 10.1080/22221751.2024.2352434. Epub 2024 Jun 11. Emerg Microbes Infect. 2024. PMID: 38712637 Free PMC article.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee AW, Liu K, Lhomme E, Blie J, McCullough J, Onorato MT, Connor L, Simon JK, Dubey S, VanRheenen S, Deutsch J, Owens A, Morgan A, Welebob C, Hyatt D, Nair S, Hamzé B, Guindo O, Sow SO, Beavogui AH, Leigh B, Samai M, Akoo P, Serry-Bangura A, Fleck S, Secka F, Lowe B, Watson-Jones D, Roy C, Hensley LE, Kieh M, Coller BG; PREVAC Study Team. Lee AW, et al. Among authors: hensley le. Clin Infect Dis. 2024 Apr 10;78(4):870-879. doi: 10.1093/cid/ciad693. Clin Infect Dis. 2024. PMID: 37967326 Free PMC article. Clinical Trial.
Vector induced humoral responses after rVSVΔG-ZEBOV-GP immunization identify vaccinated individuals and correlate with Ebola virus glycoprotein antibodies.
Chandrasekaran P, Berry IM, Callier V, Anthony SM, Hensley K, Kuhn JH, Shaw-Saliba K, Kennedy SB, Kieh M, Browne SM, Crozier I, Davey RT, Lane HC, Hensley LE, Follmann DA. Chandrasekaran P, et al. Among authors: hensley le. J Infect Dis. 2024 Dec 24:jiae632. doi: 10.1093/infdis/jiae632. Online ahead of print. J Infect Dis. 2024. PMID: 39718991
Enhancing reproducibility in single cell research with biocytometry: An inter-laboratory study.
Fikar P, Alvarez L, Berne L, Cienciala M, Kan C, Kasl H, Luo M, Novackova Z, Ordonez S, Sramkova Z, Holubova M, Lysak D, Avery L, Caro AA, Crowder RN, Diaz-Martinez LA, Donley DW, Giorno RR, Reed IKG, Hensley LL, Johnson KC, Kim AY, Kim P, LaGier AJ, Newman JJ, Padilla-Crespo E, Reyna NS, Tsotakos N, Al-Saadi NN, Appleton T, Arosemena-Pickett A, Bell BA, Bing G, Bishop B, Forde C, Foster MJ, Gray K, Hasley BL, Johnson K, Jones DJ, LaShall AC, McGuire K, McNaughton N, Morgan AM, Norris L, Ossman LA, Rivera-Torres PA, Robison ME, Thibodaux K, Valmond L, Georgiev D. Fikar P, et al. Among authors: hensley ll. PLoS One. 2024 Dec 9;19(12):e0314992. doi: 10.1371/journal.pone.0314992. eCollection 2024. PLoS One. 2024. PMID: 39652549 Free PMC article.
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.
Valayer S, Alexandre M, Prague M, Beavogui AH, Doumbia S, Kieh M, Greenwood B, Leigh B, Poupelin M, Schwimmer C, Sow SO, Berry IM, Kuhn JH, Fusco D, Cauwelaert ND, Watson-Jones D, Thiébaut R, Lévy Y, Yazdanpanah Y, Richert L, Lhomme E; PREVAC Study Team; Aboulhab J, Aguirre-MacKenzie M BS, Akoo P MB, ChB, Akpa E MSN, MPH, RN, Akpata R, Albert S BA, MPH, Ale BM MD, MSc, MPH, Alimamy-Bangura S MB, ChB, Andong P MSt, Andrews BC, Anoma S, Atri N MPH, CPH, Augier A MCom, Awuondo K MSc, Ayouba A, Badio M MSc, Bagayoko A, Balde A MPH, Balssa J PharmD, Bangura LM BSc, Barrington K MPA, Barte de Saint Fare E BA, Baseler B MS, Bauder A BA, PMP, Bauduin C MSc, Bawo L MSc, Beavogui AH MD, PhD, Belson M BS, Ben-Farhat S MEng, Bererd M BS, Bernaud N MSc, Beyslow T PharmD, Biai N MSc, Billioux J, Billouin-Frazier S MSc, Binachon B MD, MPH, Blie J MSc, Bockstal V, Boison P MS, Bolay F, Boly A MM, Bonawitz RE MD, MS, Borg AG MCM, Bosompem S PharmD, MSc, Bozman C MSc, Brady T MPH, Browne S RN, BSN, Bullis R, Cagniard B, Cahill K RN, MSc, CCRC, RAC, Cai Y, Camara AA MSc, Camara AK, Camara AM, Campagne A, Campion C MSc, Cantan A BSc, Cash J BS, Chai SP BBio-MedSc, Chambelin F MHist, Chea M BSc, Chêne… See abstract for full author list ➔ Valayer S, et al. Emerg Microbes Infect. 2025 Dec;14(1):2432353. doi: 10.1080/22221751.2024.2432353. Epub 2024 Dec 9. Emerg Microbes Infect. 2025. PMID: 39559990 Free PMC article. Clinical Trial.
Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018-2024: Predominance of zoonotic transmission.
Kinganda-Lusamaki E, Amuri-Aziza A, Fernandez-Nuñez N, Makangara-Cigolo JC, Pratt C, Vakaniaki EH, Hoff NA, Luakanda-Ndelemo G, Akil-Bandali P, Nundu SS, Mulopo-Mukanya N, Ngimba M, Modadra-Madakpa B, Diavita R, Paku-Tshambu P, Pukuta-Simbu E, Merritt S, O'Toole Á, Low N, Nkuba-Ndaye A, Kavunga-Membo H, Shongo Lushima R, Liesenborghs L, Wawina-Bokalanga T, Vercauteren K, Mukadi-Bamuleka D, Subissi L, Muyembe-Tamfum JJ, Kindrachuk J, Ayouba A, Rambaut A, Delaporte E, Tessema S, D'Ortenzio E, Rimoin AW, Hensley LE, Mbala-Kingebeni P, Peeters M, Ahuka-Mundeke S. Kinganda-Lusamaki E, et al. Among authors: hensley le. Cell. 2025 Jan 9;188(1):4-14.e6. doi: 10.1016/j.cell.2024.10.017. Epub 2024 Oct 24. Cell. 2025. PMID: 39454573 Free article.
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial.
Davey RT Jr, Collins GL, Rouphael N, Poliquin G, McConnell R, Grubbs G, Moir SL, Langley JM, Teitelbaum M, Hewlett AL, McLellan SLF, Bhadelia N, Raabe VN, Mulligan MJ, Maljkovic Berry I, Dighero-Kemp B, Kurtz JR, Hensley LE, Dozier NCE, Marron LCB, DuChene A, Kuhn JH, Brown SK, Khurana S, Lane HC, Neaton JD. Davey RT Jr, et al. Among authors: hensley le. Lancet Microbe. 2024 Nov;5(11):100923. doi: 10.1016/S2666-5247(24)00163-0. Epub 2024 Oct 4. Lancet Microbe. 2024. PMID: 39374605 Free article. Clinical Trial.
First imported Cases of MPXV Clade Ib in Goma, Democratic Republic of the Congo: Implications for Global Surveillance and Transmission Dynamics.
Mukadi-Bamuleka D, Kinganda-Lusamaki E, Mulopo-Mukanya N, Amuri-Aziza A, O'Toole Á, Modadra-Madakpa B, Ndongala GM, Vakaniaki EH, Merritt S, Kacita C, Maboko GL, Makangara-Cigolo JC, Ngimba M, Lokilo E, Pukuta-Simbu E, Luakanda G, Bodisa-Matamu T, Kalimuli ZP, Akil-Bandali P, Kavira S, Jansen D, Kamaliro AK, Muhindo-Milonde E, Mufungizi J, Hamisi YB, Kavunga H, Tshiani O, Nundu SS, Liesenborghs L, Hoff NA, Nachega J, Shongo R, Ayouba A, Pilarowski G, Mangolopa AK, Ebondo AK, Low N, Shaw SY, Wilkinson S, Tessema SK, Subissi L, Delaporte E, Vercauteren K, Wawina-Bokalanga T, Rimoin AW, Peeters M, Loman N, Rambaut A, Muyembe-Tamfum JJ, Hensley LE, Kindrachuk J, Mbala-Kingebeni P, Ahuka-Mundeke S. Mukadi-Bamuleka D, et al. Among authors: hensley le. medRxiv [Preprint]. 2024 Sep 16:2024.09.12.24313188. doi: 10.1101/2024.09.12.24313188. medRxiv. 2024. PMID: 39371169 Free PMC article. Preprint.
Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study.
Mukadi-Bamuleka D, Edidi-Atani F, Morales-Betoulle ME, Legand A, Nkuba-Ndaye A, Bulabula-Penge J, Mbala-Kingebeni P, Crozier I, Mambu-Mbika F, Whitmer S, Tshiani Mbaya O, Hensley LE, Kitenge-Omasumbu R, Davey R, Mulangu S, Fonjungo PN, Wiley MR, Klena JD, Peeters M, Delaporte E, van Griensven J, Ariën KK, Pratt C, Montgomery JM, Formenty P, Muyembe-Tamfum JJ, Ahuka-Mundeke S; EBOV Persistence Study Group. Mukadi-Bamuleka D, et al. Among authors: hensley le. Lancet Microbe. 2024 Oct;5(10):100905. doi: 10.1016/S2666-5247(24)00137-X. Epub 2024 Sep 3. Lancet Microbe. 2024. PMID: 39236738 Free PMC article.
337 results